|
藥明合聯生物技術有限公司, 02268.HK - 綜合損益表 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
營業額 |
4,059,840 |
2,638,825 |
1,799,488 |
1,702,664 |
1,543,920 |
1,531,102 |
1,434,379 |
1,428,235 |
1,224,297 |
724,793 |
562,019 |
267,586 |
經營溢利 |
991,727 |
1,013,971 |
293,248 |
285,840 |
322,330 |
367,288 |
294,115 |
319,257 |
294,832 |
183,770 |
145,684 |
57,495 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
聯營公司 |
0 |
67,000 |
94,000 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
除稅前經營溢利 |
991,727 |
1,080,971 |
387,248 |
285,840 |
322,330 |
367,288 |
294,115 |
319,257 |
294,832 |
183,770 |
145,684 |
57,495 |
稅項 |
266,049 |
90,848 |
76,615 |
61,959 |
49,360 |
76,822 |
43,875 |
43,290 |
38,283 |
13,093 |
13,041 |
15,223 |
少數股東權益 |
64,637 |
28,142 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4,736 |
6,247 |
1,990 |
股東應占溢利 |
661,041 |
961,981 |
310,633 |
223,881 |
272,970 |
290,466 |
250,240 |
275,967 |
256,549 |
165,941 |
126,396 |
40,282 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
單位 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
195,189 |
139,140 |
108,049 |
97,713 |
83,413 |
65,034 |
56,899 |
44,066 |
31,434 |
23,808 |
17,940 |
11,262 |
利息 |
219,860 |
97,246 |
77,429 |
72,818 |
67,754 |
60,256 |
50,340 |
31,057 |
27,863 |
22,722 |
21,814 |
14,475 |
利息撥作發展資本 |
273 |
2,393 |
5,397 |
4,911 |
8,939 |
20,366 |
13,802 |
10,776 |
5,592 |
4,503 |
3,318 |
1,033 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
26.83 |
8.4 |
19.78 |
21.68 |
15.31 |
20.92 |
14.92 |
13.56 |
12.98 |
7.12 |
8.95 |
26.48 |
營業額增長(%) |
53.85 |
46.64 |
5.69 |
10.28 |
0.84 |
6.74 |
0.43 |
16.66 |
68.92 |
28.96 |
110.03 |
|
股東應占溢利增長(%) |
-31.28 |
209.68 |
38.75 |
-17.98 |
-6.02 |
16.07 |
-9.32 |
7.57 |
54.6 |
31.29 |
213.78 |
|
核數師意見 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|